- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sophia Genetics SA (SOPH)
Sophia Genetics SA stock price live, this page displays NASDAQ SOPH stock exchange data. View the SOPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sophia Genetics SA real time stock price chart below.
What Is the Sophia Genetics SA Stock Price Today?
The Sophia Genetics SA stock price today is 5.670.
What Is the Stock Symbol for Sophia Genetics SA?
The stock symbol for Sophia Genetics SA is "SOPH."
What Stock Exchange Does Sophia Genetics SA Trade On?
Sophia Genetics SA is listed and trades on the NASDAQ stock exchange.
Is Sophia Genetics SA a Good Stock to Buy?
Determining whether Sophia Genetics SA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOPH quote. (ISIN: CH1125843347)
What Is the Sophia Genetics SA Stock Price Today?
The Sophia Genetics SA stock price today is 5.670.
What Is the Stock Symbol for Sophia Genetics SA?
The stock symbol for Sophia Genetics SA is "SOPH."
What Stock Exchange Does Sophia Genetics SA Trade On?
Sophia Genetics SA is listed and trades on the NASDAQ stock exchange.
Is Sophia Genetics SA a Good Stock to Buy?
Determining whether Sophia Genetics SA, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SOPH quote. (ISIN: CH1125843347)
Fair Value
An estimate of a Sophia Genetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.550
5.860
52 wk Range
2.920
6.770
Earnings results expected tomorrow
1/2
Fair Value
An estimate of a Sophia Genetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.5505.860
52 wk Range
2.9206.770
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SOPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Sophia Genetics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
9.000
Upside
+58.73%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High return over the last year
Form 144 SOPHIA GENETICS SA For: 25 June- Investing.com
Form 144 SOPHIA GENETICS SA For: 22 June- Investing.com
Form 144 SOPHIA GENETICS SA For: 7 July- Investing.com
- Form 144 SOPHIA GENETICS SA For: 7 July
- Investing.com
Form 144 SOPHIA GENETICS SA For: 6 July- Investing.com
Form 144 SOPHIA GENETICS SA For: 29 June- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 9.000
(+58.73% Upside)
Sophia Genetics SA SWOT Analysis
Data-Driven Growth | SOPHiA GENETICS expands its customer base, adding 20 new clients and achieving 17% year-over-year volume growth, showcasing resilience in a challenging market |
Market Headwinds | Explore the impact of conservative biopharma spending and regional softness on SOPHiA's revenue projections, and the company's strategic response |
Future Prospects | Delve into SOPHiA's upcoming MSK liquid biopsy offerings and their potential to drive significant revenue growth in fiscal year 2025 |
Financial Outlook | Analyst price targets range from $5 to $7, with management confident in achieving operating profitability within two years despite current market challenges |
Sophia Genetics SA Earnings Call Summary for Q4/2024
- Q4 2024 EPS of -0.23 missed forecast by 0.02; revenue of $17.7M met expectations with 4% YoY growth
- Stock fell 8.68% to $3.26 in premarket trading, reflecting investor concerns over earnings miss
- 2025 revenue guidance: $72M-$76M (10-17% growth); adjusted EBITDA breakeven targeted for end of 2026
- Platform analysis volume grew 11% to 352,000 patients in 2024; strong growth in North America and Asia Pacific
- New product launches and strategic market expansion highlighted; over 60 opportunities for MSK Access and Impact products
Last Updated: 04/03/2025, 15:24
Read Full TranscriptEarnings
Latest Release
May 05, 2026
EPS / Forecast
-0.27 / -0.23
Revenue / Forecast
21.7M / 20.39M
Compare SOPH to Peers and Sector
Metrics to compare | SOPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.9x | −1.3x | −0.4x | |
PEG Ratio | 0.33 | 0.00 | 0.00 | |
Price/Book | 10.4x | 0.8x | 2.6x | |
Price / LTM Sales | 5.9x | 0.9x | 3.0x | |
Upside (Analyst Target) | 49.9% | 11.7% | 56.0% | |
Fair Value Upside | Unlock | 35.0% | 9.1% | Unlock |
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sophia Genetics (SOPH) Stock Price Today?
The Sophia Genetics stock price today is 5.670 USD.
What Stock Exchange Does Sophia Genetics Trade On?
Sophia Genetics is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Sophia Genetics?
The stock symbol for Sophia Genetics is "SOPH."
What Is the Sophia Genetics Market Cap?
As of today, Sophia Genetics market cap is 475.690M USD.
What Is Sophia Genetics's Earnings Per Share (TTM)?
The Sophia Genetics EPS (TTM) is -1.178.
When Is the Next Sophia Genetics Earnings Date?
Sophia Genetics will release its next earnings report on Aug 04, 2026.
From a Technical Analysis Perspective, Is SOPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Sophia Genetics Stock Split?
Sophia Genetics has split 0 times.
How Many Employees Does Sophia Genetics Have?
Sophia Genetics has 415 employees.
What is the current trading status of Sophia Genetics (SOPH)?
As of Aug 03, 2026, Sophia Genetics (SOPH) is trading at a price of 5.670 USD, with a previous close of 5.670 USD. The stock has fluctuated within a day range of 5.550 USD to 5.860 USD, while its 52-week range spans from 2.920 USD to 6.770 USD.
What Is Sophia Genetics (SOPH) Price Target According to Analysts?
The average 12-month price target for Sophia Genetics is 9.000 USD, with a high estimate of 12 USD and a low estimate of 7 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +58.73% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.